Opinion
Video
Author(s):
A panelist discusses how evidence-based protocols for managing infusion-related reactions have reduced hesitancy among health care providers to use agents like amivantamab, empowered the entire care team with knowledge, and balanced the benefits and challenges of oral vs intravenous (IV) chemotherapy administration in relation to patient autonomy, adherence, and quality of life.
Impact of Evidence-Based Approaches on Treatment Implementation: Summary for Physicians
Infusion Hesitancy with High-Risk Agents
Oral vs IV Therapy Considerations
Oral Therapy Advantages
Oral Therapy Challenges
IV Therapy Considerations
Clinical Approach
The ideal treatment approach requires individualizing therapy based on both clinical factors and patient-specific considerations.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.